IN THE euthyroid patient, rapid supraventricular tachyeardias occur and are often resistant to prophylactic treatment with quinidine or pronestyl.' In an attempt to evaluate the effect of radioactive iodine in cases of supraventricular tachycardia resistant to antiarrhythmnic drugs, the authors treated 25 such patients with radioactive iodine and observed them for periods up to 6 years.2 In all instances prophylactic treatment with antiarrhythmic drugs had failed to prevent recurrent attacks. Twenty-two of these patients had arteriosclerotic heart disease and 3 had rheumatic heart disease. Manv of the patients had recurrent attacks as often as 4 times a day. In many instances, during the paroxysm oe tachycardia, the patient suffered severe anginal discomfort. All patients were considered euthyroid on the basis of clinical examination by 3 physicians and normal laboratory findings, including serum protein-bound iodine and radioactive iodine uptake.
The patients with arteriosclerotic heart disease were selected from private practice. In these patients, the clinical history and the resting electrocardiogram or Master 2-step test revealed indications of coronary artery disease. The Paroxysms then recurred almost daily. An additional radioactive iodine treatment of 29 me. was therefore given and the attacks continued. At the end of the fifteenth month the protein-bound iodine was 1.3 meg. per 100 ml., and the blood cholesterol was 288 mg. per cent. In this patient, the result was classified as poor. She was subsequently readmitted to the Cedars of Lebanon Hospital Clinic with subacute bacterial endocarditis and had chronic atrial fibrillation.
RESULTS
A total of 25 patients were treated with radioactive iodine. Of these, 20 had a good result, 17 patients had no paroxysms of arrhythmia, and 3 had an occasional paroxysm following treatment with radioactive iodine. However, in these latter patients, the paroxysms were induced by surgery or the ingestion of excessive thyroid.
Three other patients had a fair result, viz., no recurrence of tachycardia after treatment for periods of 12 to 14 months, but following this period, they experienced occasional episodes of tachycardia, much reduced in number and severity. Because there was a decided improvement maintained for a 12 to 14-month period, the results in these 3 patients were classified as fair. One of the patients was subsequently found to require further treatment with radioactive iodine because of return of function of the thyroid gland.
The results in 2 patients were classified as poor. These patients were both psychotic and difficult to evaluate.
Two patients who had severe angina during their paroxysms of tachycardia continued to experience occasional episodes of tachycardia after treatment with I131 but no longer suffered anginal pain with these attacks. Pain no longer occurred in association with the tachycardia although the ventricular rate !904 was at least as rapid as it was in the paroxysms observed before treatment.
DISCUSSION
The mechanism of action of radioactive iodine in abating and reducing the number of attacks of paroxysmal tachycardia in euthyroid subjects is difficult to understand. Consideration was given to the possibility that relative hyperthyroidism might have been present in these patients, despite the absence of any clinical or laboratory evidence for thyroid hyperfunction. However, it is extremely improbable that all the patients in this series who Ullrick and Whitehorn16 have demonstrated that under the influence of thyroid hormone the basic atrial metabolism is more markedly increased than that of the ventricle. The finding of an unusual sensitivity of the atrium to the action of thyroid hormone offers a physiologic basis for the atrial tachyeardias that are so characteristic of hyperthyroid heart disease. By treatment of the euthyroid patient with radioiodine we probably decrease the level of atrial metabolism and thus the excitability. The change in atrial metabolism probably prevents recurrence of the tachyeardias. Freedberg7 stated "a significant number of euthyroid patients with persistent auricular fibrillation have demonstrated a reversal to normal sinus rhythm after the induction of hypothyroidism."
It is interesting that 2 of 3 patients who previously had precordial pain during the paroxysms, no longer had pain with recurrent attacks after treatment with r'adioa(tive(' iodine. It has been suggested that radioactive iodine, when administered for treatment of angina pectoris, lessens the work of the heart. However, in our 3 patients with recurrent paroxysms of tachycardia after J11:1 treatment, the heart rate was at least as fast as before treatment. Therefore, it seems doubtful that the work load of the heart was really reduced by the 1l3l during a pain-free episode of tachycardia. however, it is possible that in the hypothyroid state the metabolic requirements of the myocardium may be reduced. Thus, with lessened demand for coronary flow, myocardial ischemia and angina might be less likely to occur. This could account for the brilliant success of the treatment for angina pectoris by the induction of hypothyroidism. 8 Whatever may be the mechanism by which the reduction ill thyroid function decreases the incidence of arrhythmias, it seems clear that the administration of 1131 is a simple, convenient, and relatively safe method for producing hypothyroidism and preventing supraventricular cardiac arrhythmias. 
